Cargando…
Breast cancer resistance to chemotherapy: When should we suspect it and how can we prevent it?
Chemotherapy is an essential treatment for breast cancer, inducing cancer cell death. However, chemoresistance is a problem that limits the effectiveness of chemotherapy. Many factors influence chemoresistance, including drug inactivation, changes in drug targets, overexpression of ABC transporters,...
Autores principales: | Prihantono, Faruk, Muhammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519754/ https://www.ncbi.nlm.nih.gov/pubmed/34691411 http://dx.doi.org/10.1016/j.amsu.2021.102793 |
Ejemplares similares
-
We Can, but Should We?
por: Kelly, Robert Brett
Publicado: (2016) -
Inclisiran: How Widely and When Should We Use It?
por: Pirillo, Angela, et al.
Publicado: (2022) -
Neoadjuvant chemotherapy response, disease-free survival, and overall survival of breast cancer in a single institution
por: Prihantono, et al.
Publicado: (2023) -
When we can trust computers (and when we can't)
por: Coveney, Peter V., et al.
Publicado: (2021) -
Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
por: Nedeljković, Milica, et al.
Publicado: (2019)